DK1017377T3 - Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande - Google Patents

Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande

Info

Publication number
DK1017377T3
DK1017377T3 DK98946704T DK98946704T DK1017377T3 DK 1017377 T3 DK1017377 T3 DK 1017377T3 DK 98946704 T DK98946704 T DK 98946704T DK 98946704 T DK98946704 T DK 98946704T DK 1017377 T3 DK1017377 T3 DK 1017377T3
Authority
DK
Denmark
Prior art keywords
substituted
aminotetralins
cytokine
treatment
inflammatory conditions
Prior art date
Application number
DK98946704T
Other languages
English (en)
Inventor
Piero Foresta
Vito Ruggiero
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1017377T3 publication Critical patent/DK1017377T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98946704T 1997-09-22 1998-09-18 Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande DK1017377T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000569A IT1294932B1 (it) 1997-09-22 1997-09-22 Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie
PCT/IT1998/000250 WO1999015160A2 (en) 1997-09-22 1998-09-18 Use of 6,7-substituted 2-aminotetralines suitable for preparing pharmaceutical composition for the therapeutic treatment of inflammatory and/or autoimmune pathologies

Publications (1)

Publication Number Publication Date
DK1017377T3 true DK1017377T3 (da) 2002-03-04

Family

ID=11405258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98946704T DK1017377T3 (da) 1997-09-22 1998-09-18 Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande

Country Status (17)

Country Link
US (1) US6242497B1 (da)
EP (1) EP1017377B1 (da)
JP (1) JP2001517618A (da)
KR (1) KR20010030670A (da)
CN (1) CN1276721A (da)
AT (1) ATE209910T1 (da)
AU (1) AU735369B2 (da)
BR (1) BR9812489A (da)
CA (1) CA2303918A1 (da)
DE (1) DE69802828T2 (da)
DK (1) DK1017377T3 (da)
ES (1) ES2167942T3 (da)
IT (1) IT1294932B1 (da)
MX (1) MXPA00002774A (da)
NZ (1) NZ503391A (da)
PT (1) PT1017377E (da)
WO (1) WO1999015160A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
JP5738875B2 (ja) 2009-10-16 2015-06-24 エピオメド セラピューティクス， インク． 催吐治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
IT1278045B1 (it) * 1995-03-09 1997-11-17 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Also Published As

Publication number Publication date
ES2167942T3 (es) 2002-05-16
AU9366198A (en) 1999-04-12
AU735369B2 (en) 2001-07-05
DE69802828T2 (de) 2002-07-18
DE69802828D1 (de) 2002-01-17
CN1276721A (zh) 2000-12-13
PT1017377E (pt) 2002-04-29
WO1999015160A2 (en) 1999-04-01
WO1999015160A3 (en) 1999-05-20
EP1017377B1 (en) 2001-12-05
MXPA00002774A (es) 2002-10-31
BR9812489A (pt) 2000-09-26
KR20010030670A (ko) 2001-04-16
ATE209910T1 (de) 2001-12-15
NZ503391A (en) 2001-06-29
US6242497B1 (en) 2001-06-05
CA2303918A1 (en) 1999-04-01
EP1017377A2 (en) 2000-07-12
JP2001517618A (ja) 2001-10-09
IT1294932B1 (it) 1999-04-23
ITRM970569A1 (it) 1999-03-22

Similar Documents

Publication Publication Date Title
FI935585A0 (fi) Pyrrolopyrimidiner
DK0901374T3 (da) Tetrahydropteridiner og pyridylpiperaziner til behandling af neurologiske forstyrrelser
FI964004A0 (fi) Serotoniiniantagonistien (5HT3) käyttö fibromyalgian hoitoon
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
EA199800667A1 (ru) Новые фенантридины
NO965378D0 (no) Pyrazolo- og pyrolopyridiner
DK0981607T3 (da) Modificeret arginin-deiminase
DE69939864D1 (de) Ppar-gamma modulatoren
ID23374A (id) Halogenopirimidin
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
BR9711586A (pt) Compostos e uso dos mesmo
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
ATE203519T1 (de) Chinolinderivate als antimalariamittel
BG100248A (bg) Инхибитори на скваленсинтетаза
DK0928183T3 (da) Anvendelse af 1-hydroxy-2-pyridoner til behandling af seborrhoisk dermatitis
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DK1017377T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til behandling af af cytokin fremkaldte inflammatoriske tilstande
TR199700416A2 (xx) Fluorinlenmi� vitamin D3 analoglar�.
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
ATE246690T1 (de) Thiazolopyrimidine verwendbar als tnf-alpha inhibitoren
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
PT950056E (pt) N-(piridinilamino) isoindolinas e compostos relacionados
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer